News
 

An innovative study from the University of Otago links retinal blood vessel and nerve fiber health to dementia risk.

A Parkinson's rat study shows that combining stem cell-derived neuron transplants with voluntary exercise significantly enhances motor control vs. transplant alone.
Exercise boosts graft integration and activates key pathways like BDNF, GDNF, and MAPK-ERK.
💡 What if movement didn't just help... but healed?

A U.S. trial uses reprogrammed stem cells from patients' own blood to generate dopamine neurons—no immunosuppression needed!
✅ Personalized therapy
✅ Reduced rejection risk
Three patients treated so far with 12-month follow-up. Precision medicine is already happening.

An Iranian study (2020–2023) found that 1.6% of MS patients developed brain tumors—mainly pituitary adenomas and meningiomas.
⌛ Median time: 10 years post-MS diagnosis
⚠️ Be alert to atypical symptoms—it's not always MS.

A pioneering study reveals that an experimental drug that removes amyloid plaques from the brain can reduce the risk of developing dementia by up to 50% in people with genetic predisposition to Alzheimer's.

A new study reveals that blood vessels in the retina may show early signs of dementia and Alzheimer's risk.

A new study reveals that people whose biological age is greater than their chronological age might be more likely to develop dementia.

Summary: A recent study demonstrates that exercise significantly improves the effectiveness of neuron transplants derived from stem cells in Parkinson's disease models.

Researchers at the University of Florida have developed an AI-driven software that significantly enhances the diagnosis of Parkinson's disease and related disorders. The system, named AIDP (Automated Imaging Differentiation for Parkinsonism), employs MRI scans and machine learning algorithms to identify patterns of neurodegeneration, achieving...

An international study led by Washington University in St. Louis has found that an experimental anti-amyloid drug can reduce the risk of developing dementia by 50% in individuals with genetic mutations that predispose them to early-onset Alzheimer's. In a subgroup of participants who began treatment symptom-free and continued it for eight years, a...